Setiadi, A Francesca <br/><br/>
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Journal of neuroimmunology  07 2019 
 - 147-154 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8421 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2019.04.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Blood-Brain Barrier<br/>Cells, Cultured<br/>Encephalomyelitis, Autoimmune, Experimental--physiopathology<br/>Endothelial Cells--drug effects<br/>Female<br/>Humans<br/>Immunization, Passive<br/>Interleukin-17--antagonists & inhibitors<br/>Interleukin-6--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--cerebrospinal fluid<br/>Receptors, Interleukin-6--physiology<br/>Recombinant Proteins--pharmacology<br/>Young Adult